共 40 条
[1]
Hu D.Y., Xu X.P., Effective control of H-type hypertension: A new way to prevent stroke, Chin J Intern Med, 47, (2008)
[2]
Li J.P., Lu X.Z., Huo Y., Li N.F., Song L., Sun Y.X., Et al., Expert consensus on diagnosis and treatment of H-type hypertension, Chin J Hypertens, 24, (2016)
[3]
Graham I.M., Daly L.E., Refsrum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Et al., Plasma homocysteine as a risk factor for vascular disease, Eur Concerted Action Project JAMA, 277, (1997)
[4]
Reducing Plasma Homocysteine: A Novel Approach to Stroke Prevention in Chinese Hypertensive Patients[Z]. Completer: Li JP, Huo Y, Xu XP, Sun NL, Chen YD, Zhang BW, et al
[5]
Huo Y., Li J., Qin X., Huang Y., Wang X., Gottesman R.F., Et al., Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial, JAMA, 313, (2015)
[6]
Wang Y.J., Liu L.S., Rao K.Q., Xu X.P., Strategies for stroke prevention in China: control hypertension and high homocysteine level at the same time, Natl Med J China, 88, (2008)
[7]
Penton D., Czogalla J., Loffing J., Dietary potassium and the renal control of salt balance and blood pressure, Pflugers Arch, 467, (2015)
[8]
Craddick S.R., Elmer P.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Swain M.C., The DASH diet and blood pressure, Curr Atheroscler Rep, 5, (2003)
[9]
Huang Y., Van Horn L., Tinker L.F., Neuhouser M.L., Carbone L., Mossavar-Rahmani Y., Et al., Measurement error corrected sodium and potassium intake estimation using 24-hour urinary excretion, Hypertension, 63, (2014)
[10]
Du X., Fang L., Xu J., Chen X., Zhang J., Bai Y., Et al., Prevalence, awareness, treatment and control of hypertension and sodium intake in Zhejiang Province, China: A cross-sectional survey in 2017, PloS One, 14, (2019)